Physical Activity Behavior Change for Older Adults After Dysvascular Amputation (PABC)
Primary Purpose
Amputation, Diabetes Mellitus, Type 2, Peripheral Artery Disease
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Physical Activity Behavior Change (PABC)
Physical Activity Behavior Change (PABC)
Sponsored by
About this trial
This is an interventional treatment trial for Amputation focused on measuring Amputation, Physical Activity, Rehabilitation
Eligibility Criteria
Inclusion Criteria:
- Lower limb amputation 1-5 years prior to enrollment
- Type 2 Diabetes Mellitus and/or
- Peripheral Artery Disease
- Ambulatory using a lower limb prosthesis
- English speaking
Exclusion Criteria:
- Traumatic or cancer-related etiology of the lower limb amputation
Unstable heart condition, including:
- unstable angina
- uncontrolled cardiac dysrhythmia
- acute myocarditis
- acute pericarditis
- Uncontrolled hypertension
- Acute systemic infection
- Prisoner
- Decisionally challenged volunteers
- Cancer
- Recent cerebral vascular accident (within two years)
- lower extremity wound or ulcer that limits ability to ambulate
Sites / Locations
- Rocky Mountain Regional VA Medical Center, Aurora, CO
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Early PABC Intervention
Wait-List Control Intervention
Arm Description
GROUP 1 will participate in the Physical Activity Behavior Change (PABC) intervention phase during the first 3 months. GROUP 1 will then participate in a non-exercise control phase during the second 3 months.
GROUP 2 will participate in a non-exercise control phase during the first 3 months. GROUP 2 will then participate in the Physical Activity Behavior Change (PABC) intervention phase in the second 3 months.
Outcomes
Primary Outcome Measures
Retention Rate
Retention rate will be measured as the percent of participants enrolled in the intervention who complete the intervention.
Dose Goal Attainment
Dose goal attainment will be measured as the percent of participants in the intervention phase of the study who meet the dose goal of an average 3% increase in daily steps.
Acceptability
Acceptability will be measured using the mean score of the Intrinsic Motivation Inventory - Interest / Enjoyment Subscale. The scores range from 1 to 7, with higher numbers indicating higher acceptability, and a null value of 5.0.
Study-Related Adverse Events
Safety will be assessed as differences in rates of study-related adverse events between GROUP 1 and GROUP 2 during the first three months, when GROUP 1 is in the intervention phase and GROUP 2 is in the non-intervention control phase.
Secondary Outcome Measures
Accelerometer-Based Physical Activity
Physical activity counts will be measured using a waist-mounted accelerometer-based physical activity monitor (Actigraph). The outcome will be average daily physical activity counts.
Late Life Function and Disability Scale, Frequency
The Late Life Function and Disability Scale (LLFDSI) will be used to assess the participant-reported disability at each test point. Scores range from 0 to 100, with higher scores indicating higher disability.
Accelerometer-Based Physical Activity
Physical activity counts will be measured using a waist-mounted accelerometer-based physical activity monitor (Actigraph). The outcome will be average daily physical activity counts.
Late Life Function and Disability Scale, Frequency
The Late Life Function and Disability Scale (LLFDSI) will be used to assess the participant-reported disability at each test point. Scores range from 0 to 100, with higher scores indicating higher disability.
Late Life Function and Disability Scale, Limitation
The Late Life Function and Disability Scale (LLFDSI) will be used to assess the participant-reported disability at each test point. Scores range from 0 to 100, with higher scores indicating higher disability.
Late Life Function and Disability Scale, Limitation
The Late Life Function and Disability Scale (LLFDSI) will be used to assess the participant-reported disability at each test point. Scores range from 0 to 100, with higher scores indicating higher disability.
Full Information
NCT ID
NCT02738086
First Posted
March 16, 2016
Last Updated
February 6, 2020
Sponsor
VA Office of Research and Development
1. Study Identification
Unique Protocol Identification Number
NCT02738086
Brief Title
Physical Activity Behavior Change for Older Adults After Dysvascular Amputation
Acronym
PABC
Official Title
Physical Activity Behavior Change for Older Veterans After Dysvascular Amputation
Study Type
Interventional
2. Study Status
Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
July 1, 2016 (Actual)
Primary Completion Date
February 22, 2019 (Actual)
Study Completion Date
February 22, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
VA Office of Research and Development
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This pilot study will use mobile-health technology to deliver an intervention designed for lasting physical activity behavior change. The study will assess the feasibility of using the Physical Activity Behavior Change(PABC) intervention for Veterans with lower limb amputation. This intervention will be delivered using wrist-worn wearable activity sensors and a home-based tablet computer to allow real-time physical activity feedback and video interface between the participants and the therapist.
Detailed Description
This pilot study will assess the feasibility of using the Physical Activity Behavior Change(PABC) intervention for Veterans with dysvascular lower limb amputation. In addition, preliminary efficacy of the PABC intervention will be assessed using a two-group randomized cross-over design. Testing will occur at baseline (pre-intervention), three months (end of intervention), and six months. The primary aim is to determine feasibility of using the PABC intervention with Veterans who have dysvascular amputation by measuring:
participant retention
dose goal attainment
participant acceptability
safety The secondary aim is to preliminary assess efficacy of the PABC intervention by measuring accelerometer-based physical activity and self-report disability effect sizes.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Amputation, Diabetes Mellitus, Type 2, Peripheral Artery Disease
Keywords
Amputation, Physical Activity, Rehabilitation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
31 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Early PABC Intervention
Arm Type
Experimental
Arm Description
GROUP 1 will participate in the Physical Activity Behavior Change (PABC) intervention phase during the first 3 months. GROUP 1 will then participate in a non-exercise control phase during the second 3 months.
Arm Title
Wait-List Control Intervention
Arm Type
Experimental
Arm Description
GROUP 2 will participate in a non-exercise control phase during the first 3 months. GROUP 2 will then participate in the Physical Activity Behavior Change (PABC) intervention phase in the second 3 months.
Intervention Type
Behavioral
Intervention Name(s)
Physical Activity Behavior Change (PABC)
Intervention Description
Home-based weekly sessions (30 min) using behavior change methods for promoting physical activity. Sessions will occur using home-based computer tablets for real-time video interface between the participant and therapist. Participants will wear wrist-mounted activity sensors with direct physical activity feedback during the intervention period to allow for behavioral feedback and action planning.
Intervention Type
Behavioral
Intervention Name(s)
Physical Activity Behavior Change (PABC)
Intervention Description
Home-based weekly sessions (30 min) using behavior change methods for promoting physical activity. Sessions will occur using home-based computer tablets for real-time video interface between the participant and therapist. Participants will wear wrist-mounted activity sensors with direct physical activity feedback during the intervention period to allow for behavioral feedback and action planning
Primary Outcome Measure Information:
Title
Retention Rate
Description
Retention rate will be measured as the percent of participants enrolled in the intervention who complete the intervention.
Time Frame
3 months
Title
Dose Goal Attainment
Description
Dose goal attainment will be measured as the percent of participants in the intervention phase of the study who meet the dose goal of an average 3% increase in daily steps.
Time Frame
3 months
Title
Acceptability
Description
Acceptability will be measured using the mean score of the Intrinsic Motivation Inventory - Interest / Enjoyment Subscale. The scores range from 1 to 7, with higher numbers indicating higher acceptability, and a null value of 5.0.
Time Frame
3 months
Title
Study-Related Adverse Events
Description
Safety will be assessed as differences in rates of study-related adverse events between GROUP 1 and GROUP 2 during the first three months, when GROUP 1 is in the intervention phase and GROUP 2 is in the non-intervention control phase.
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Accelerometer-Based Physical Activity
Description
Physical activity counts will be measured using a waist-mounted accelerometer-based physical activity monitor (Actigraph). The outcome will be average daily physical activity counts.
Time Frame
3 months
Title
Late Life Function and Disability Scale, Frequency
Description
The Late Life Function and Disability Scale (LLFDSI) will be used to assess the participant-reported disability at each test point. Scores range from 0 to 100, with higher scores indicating higher disability.
Time Frame
3 months
Title
Accelerometer-Based Physical Activity
Description
Physical activity counts will be measured using a waist-mounted accelerometer-based physical activity monitor (Actigraph). The outcome will be average daily physical activity counts.
Time Frame
6 months
Title
Late Life Function and Disability Scale, Frequency
Description
The Late Life Function and Disability Scale (LLFDSI) will be used to assess the participant-reported disability at each test point. Scores range from 0 to 100, with higher scores indicating higher disability.
Time Frame
6 months
Title
Late Life Function and Disability Scale, Limitation
Description
The Late Life Function and Disability Scale (LLFDSI) will be used to assess the participant-reported disability at each test point. Scores range from 0 to 100, with higher scores indicating higher disability.
Time Frame
3 months
Title
Late Life Function and Disability Scale, Limitation
Description
The Late Life Function and Disability Scale (LLFDSI) will be used to assess the participant-reported disability at each test point. Scores range from 0 to 100, with higher scores indicating higher disability.
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Lower limb amputation 1-5 years prior to enrollment
Type 2 Diabetes Mellitus and/or
Peripheral Artery Disease
Ambulatory using a lower limb prosthesis
English speaking
Exclusion Criteria:
Traumatic or cancer-related etiology of the lower limb amputation
Unstable heart condition, including:
unstable angina
uncontrolled cardiac dysrhythmia
acute myocarditis
acute pericarditis
Uncontrolled hypertension
Acute systemic infection
Prisoner
Decisionally challenged volunteers
Cancer
Recent cerebral vascular accident (within two years)
lower extremity wound or ulcer that limits ability to ambulate
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Cory L. Christiansen, PhD
Organizational Affiliation
Rocky Mountain Regional VA Medical Center, Aurora, CO
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rocky Mountain Regional VA Medical Center, Aurora, CO
City
Aurora
State/Province
Colorado
ZIP/Postal Code
80045
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
32248638
Citation
Christiansen CL, Miller MJ, Kline PW, Fields TT, Sullivan WJ, Blatchford PJ, Stevens-Lapsley JE. Biobehavioral Intervention Targeting Physical Activity Behavior Change for Older Veterans after Nontraumatic Amputation: A Randomized Controlled Trial. PM R. 2020 Oct;12(10):957-966. doi: 10.1002/pmrj.12374. Epub 2020 May 6.
Results Reference
derived
Learn more about this trial
Physical Activity Behavior Change for Older Adults After Dysvascular Amputation
We'll reach out to this number within 24 hrs